Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001348362-25-000002
Filing Date
2025-01-16
Accepted
2025-01-16 11:39:22
Documents
1
Period of Report
2025-01-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2056
  Complete submission text file 0001348362-25-000002.txt   3639
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Issuer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 704 ALEXANDER STREET VANCOUVER A1 V6A 1E3
Business Address
Bhullar Baljinder (Reporting) CIK: 0001401225 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39874 | Film No.: 25534855